Home Newsfeeds Russia is Considering Abolishing Grain Export Quota

Russia is Considering Abolishing Grain Export Quota

-Reuters Citing Interfax

byCharles Gross

October 11, 2022

1 minute read

-Reuters Citing Interfax

Avid Bioservices Q1 EPS $0.02 Misses $0.04 Estimate, Sales $36.69M Beat $33.44M Estimate

By Benzinga Newsdesk

September 6, 4:08 PM

Avid Bioservices (NASDAQ:CDMO) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.04 by 50 percent. This is a 80 percent decrease over earnings of $0.10 per share from the

CDMO

Altamira Therapeutics Announces Launch Of Bentrio In Hong Kong By Its Partner Nuance Pharma

By Benzinga Newsdesk

November 30, 9:08 AM

Hamilton, Bermuda, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Initiative is Nuance's first step in penetrating Chinese market with BentrioTM Densely populated Hong Kong (7.3 million) remains negatively impacted by

CYTO

Amphenol To Buy PCTEL At 50% Premium: Here’s Details

By Lekha Gupta

October 16, 6:01 AM

On Friday, Amphenol Corp (NYSE: APH) inked a deal to acquire PCTEL Inc (NASDAQ: PCTI)

APH

Reported On Thursday, Trinseo Announces Q4 And FY22 Expected Results And $297M Goodwill Impairment Charge; Sees Q4 Net Loss From Operations Of $367M-$362M; FY22 Net Loss From Operations Of $432M-$427M

By Benzinga Newsdesk

January 27, 1:23 AM

Fourth Quarter 2022 Expected Results Net loss from continuing operations of $367 million to $362 million and Adjusted EBITDA* of $4 million to $9 million Net loss includes

TSE

Russia is Considering Abolishing Grain Export Quota

Related Posts

Avid Bioservices Q1 EPS $0.02 Misses $0.04 Estimate, Sales $36.69M Beat $33.44M Estimate

Altamira Therapeutics Announces Launch Of Bentrio In Hong Kong By Its Partner Nuance Pharma

Amphenol To Buy PCTEL At 50% Premium: Here’s Details

Reported On Thursday, Trinseo Announces Q4 And FY22 Expected Results And $297M Goodwill Impairment Charge; Sees Q4 Net Loss From Operations Of $367M-$362M; FY22 Net Loss From Operations Of $432M-$427M